Yuanbao Inc. (YB)
NEUTRALFundamental
59
Precio
$13.80
Capitalización Bursátil
$639M
Parte 1 · Cuánto vale la empresa
Resumen
Yuanbao Inc., together with its subsidiaries, provides insurance brokerage and agency licenses services in the People's Republic of China. The company offers medical, critical illness, accident, property, and pet insurance products. Yuanbao Inc. was incorporated in 2019 and is headquartered in Beijing, the People's Republic of China.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance y Liquidez
Ingresos
$4.72B
Últimos 12 meses (hasta 31/3/2026)
Beneficio Neto
$1.40B
Últimos 12 meses (hasta 31/3/2026)
Flujo de Caja Libre
-
Patrimonio Neto Total
$399M
Pasivo Total
$4M
Ratio de Liquidez
3.48
Cobertura de Intereses
-
Deuda/EBITDA
0.00
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$45.47
Precio Actual
$13.80
Margen de Seguridad
+69.7%
Rango de Valor Justo
$29.56 - $61.39
Métodos de Estimación
Métricas de Valoración
Ratio P/E
3.28
ROE
47.9%
Ratio P/B
1.13
P/FCF
-
Margen Bruto
96.4%
ROIC
307.2%
Radar de Rentabilidad
Value Creation (Economic Moat)
ROIC
307.2%
WACC
8.0%
ROIC − WACC
+299.3 pp
ROIC exceeds the cost of capital — the company is creating value for shareholders.
Criterios de Análisis Fundamental
Superado (7)
- ROIC 307.2%
- Gross Margin 96.4%
- P/B Ratio 1.13
- Debt/Equity ratio
- Current Ratio
- Debt/EBITDA
- ROE 44.1%
Fallido (4)
- Price CAGR -33.29%
- DCF valuation (Unknown)
- Analyst Consensus 0% Buy
- Piotroski F-Score 0/9
No disponible (16)
- EPS data insufficient
- P/FCF NaN
- Dividend Payout NaN%
- Operating Margin NaN%
- Positive Free Cash Flow
- CapEx intensity
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- Revenue Growth 5Y (Finnhub)
- Earnings Surprise (no valid data)
- PEG Ratio (need PE > 0 and growth > 0)
- Earnings Quality (OCF/Net Income)
- Share Dilution (need 2+ years)
- Net Margin Trend (invalid data)
Piotroski F-Score
Preocupaciones financieras graves
Calidad de los Beneficios
Baja calidad: investigue la contabilidad
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. Rui Fang | Chairman & CEO | 48 |
| Mr. Huirui Wan | Chief Financial Officer | 35 |
| Ms. Ying Li | COO & Director | 37 |
| Mr. Bo Wang | Chief Technology Officer | 42 |
| Ms. Shuli Sun | Chief Product Officer & Director | 35 |
| Ms. Ying Le | Vice President | 35 |
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Latest News
Recent headlines for YB, sourced from Markets Gazette.